Press Releases
Imago BioSciences Expands Phase 2 Clinical Trial of Bomedemstat (IMG-7289) for the Treatment of Myelofibrosis into Hong Kong
Nov 30, 2020
Imago BioSciences to Participate in the Piper Sandler 32nd Annual Healthcare Conference
Nov 23, 2020
Imago BioSciences Raises $80 Million in Series C Financing
Nov 19, 2020
Interim Data From Imago BioSciences’ Phase 2b Study of Bomedemstat (IMG-7289) for Treatment of Myelofibrosis to Be Presented at 62nd American Society of Hematology Annual Meeting
Nov 05, 2020
Proof of Concept Data for Colorista® Capsules Used with Imago BioSciences’ Bomedemstat Presented at the AAPS Pharmsci 360 Virtual Conference
Nov 02, 2020
Displaying 21 - 25 of 46